ABIO.PA PAR
Albioma
€47.14
Last traded — delisted
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$573M
+13.1% ▲
5Y CAGR: +9.3%
Gross Profit
$390M
+6.3% ▲
5Y CAGR: +8.4%
Operating Income
$115M
-4.4% ▼
5Y CAGR: +7.8%
Net Income
$71M
+29.0% ▲
5Y CAGR: +16.6%
EPS (Diluted)
$2.22
+29.1% ▲
5Y CAGR: +15.1%
EBITDA
$215M
+2.3% ▲
5Y CAGR: +11.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $403M | $428M | $506M | $507M | $573M |
| YoY Growth | +9.6% | +6.2% | +18.1% | +0.2% | +13.1% |
| Cost of Revenue | $132M | $139M | $158M | $140M | $183M |
| Gross Profit | $272M | $289M | $348M | $367M | $390M |
| Gross Margin | 67.3% | 67.5% | 68.8% | 72.4% | 68.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 | $0 |
| Operating Expenses | $196M | $182M | $242M | $246M | $265M |
| Operating Income | $76M | $107M | $105M | $121M | $115M |
| Operating Margin | 18.8% | 25.1% | 20.8% | 23.8% | 20.1% |
| Interest Expense | $25M | $24M | $31M | $32M | $32M |
| Income Before Tax | $56M | $83M | $78M | $90M | $96M |
| Tax Expense | $12M | $30M | $24M | $26M | $24M |
| Net Income | $37M | $44M | $44M | $55M | $71M |
| Net Margin | 9.3% | 10.3% | 8.7% | 10.9% | 12.4% |
| EPS (Diluted) | $1.24 | $1.44 | $1.40 | $1.72 | $2.22 |
| EBITDA | $131M | $158M | $184M | $207M | $215M |
| Shares Outstanding | 30M | 31M | 32M | 32M | 32M |